Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

[Efficacy of combined paclitaxel/cetuximab in cutaneous squamous-cell carcinoma: A retrospective analysis of 14 patients].

Casassa E, Riffaud L, Sibaud V, Boulinguez S, Chira C, Gangloff D, Montastruc M, Lamant L, Paul C, Meyer N.

Ann Dermatol Venereol. 2020 Apr;147(4):303-306. doi: 10.1016/j.annder.2019.07.009. Epub 2020 Mar 4. French. No abstract available.

PMID:
32145990
2.

[Treatment of patients with brain metastases from a melanoma].

Modesto A, Chira C, Sol JC, Lubrano V, Boulinguez S, Pagès C, Sibaud V, Gomez-Roca C, Moyal É, Meyer N.

Cancer Radiother. 2019 Apr;23(2):147-150. doi: 10.1016/j.canrad.2018.05.006. Epub 2019 Mar 21. Review. French.

PMID:
30904418
3.

Improving Fall Detection Using an On-Wrist Wearable Accelerometer.

Khojasteh SB, Villar JR, Chira C, González VM, de la Cal E.

Sensors (Basel). 2018 Apr 26;18(5). pii: E1350. doi: 10.3390/s18051350.

4.

[Dermatologic toxicities of immune checkpoint inhibitors].

Sibaud V, Boulinguez S, Pagès C, Riffaud L, Lamant L, Chira C, Boyrie S, Vigarios E, Tournier E, Meyer N.

Ann Dermatol Venereol. 2018 May;145(5):313-330. doi: 10.1016/j.annder.2018.01.047. Epub 2018 Apr 18. Review. French.

PMID:
29678394
5.

Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy.

Godillot C, Boulinguez S, Riffaud L, Sibaud V, Chira C, Tournier E, Paul C, Meyer N.

Eur J Cancer. 2018 Feb;90:142-145. doi: 10.1016/j.ejca.2017.11.009. Epub 2017 Dec 9. No abstract available.

PMID:
29233613
6.

Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination.

Aboudaram A, Modesto A, Chaltiel L, Gomez-Roca C, Boulinguez S, Sibaud V, Delord JP, Chira C, Delannes M, Moyal E, Meyer N.

Melanoma Res. 2017 Oct;27(5):485-491. doi: 10.1097/CMR.0000000000000386.

PMID:
28858075
7.

Nomogram to predict rectal toxicity following prostate cancer radiotherapy.

Delobel JB, Gnep K, Ospina JD, Beckendorf V, Chira C, Zhu J, Bossi A, Messai T, Acosta O, Castelli J, de Crevoisier R.

PLoS One. 2017 Jun 22;12(6):e0179845. doi: 10.1371/journal.pone.0179845. eCollection 2017.

8.

Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.

Jolnerovski M, Salleron J, Beckendorf V, Peiffert D, Baumann AS, Bernier V, Huger S, Marchesi V, Chira C.

Radiat Oncol. 2017 Jun 16;12(1):99. doi: 10.1186/s13014-017-0839-3.

9.

Prescribing pattern of clozapine and other antipsychotics for patients with first-episode psychosis: a cross-sectional survey of early intervention teams.

Tungaraza TE, Ahmed W, Chira C, Turner E, Mayaki S, Nandhra HS, Edwards T, Farooq S.

Ther Adv Psychopharmacol. 2017 Mar;7(3):103-111. doi: 10.1177/2045125316683151. Epub 2016 Dec 1.

10.

S4MPLE--Sampler for Multiple Protein-Ligand Entities: Methodology and Rigid-Site Docking Benchmarking.

Hoffer L, Chira C, Marcou G, Varnek A, Horvath D.

Molecules. 2015 May 19;20(5):8997-9028. doi: 10.3390/molecules20058997.

11.

The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology.

Orsolya M, Attila-Zoltan M, Gherman V, Zaharie F, Bolboaca S, Chira C, Bodolea C, Tomuleasa C, Irimie A, Coman I, Ionescu D.

J BUON. 2015 Jan-Feb;20(1):317-24.

12.

Improving human activity recognition and its application in early stroke diagnosis.

Villar JR, González S, Sedano J, Chira C, Trejo-Gabriel-Galan JM.

Int J Neural Syst. 2015 Jun;25(4):1450036. doi: 10.1142/S0129065714500361. Epub 2014 Nov 10.

PMID:
25684369
13.

Predictability in cellular automata.

Agapie A, Andreica A, Chira C, Giuclea M.

PLoS One. 2014 Oct 1;9(10):e108177. doi: 10.1371/journal.pone.0108177. eCollection 2014.

14.

A cluster merging method for time series microarray with production values.

Chira C, Sedano J, Camara M, Prieto C, Villar JR, Corchado E.

Int J Neural Syst. 2014 Sep;24(6):1450018. doi: 10.1142/S012906571450018X. Epub 2014 Jul 24.

PMID:
25081426
15.

Random forests to predict rectal toxicity following prostate cancer radiation therapy.

Ospina JD, Zhu J, Chira C, Bossi A, Delobel JB, Beckendorf V, Dubray B, Lagrange JL, Correa JC, Simon A, Acosta O, de Crevoisier R.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1024-1031. doi: 10.1016/j.ijrobp.2014.04.027. Epub 2014 Jul 8.

PMID:
25035205
16.

Game theory and extremal optimization for community detection in complex dynamic networks.

Lung RI, Chira C, Andreica A.

PLoS One. 2014 Feb 26;9(2):e86891. doi: 10.1371/journal.pone.0086891. eCollection 2014.

17.

Deferred permanent prostate seed brachytherapy does not affect PSA outcome: results from a large retrospective cohort.

Chira C, Delouya G, Gruszczynski N, Donath D, Taussky D.

Can J Urol. 2013 Dec;20(6):7028-34.

PMID:
24331344
18.

[Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].

Liem X, Chira C, Fourquet A, Campana F, Peurien D, Fournier-Bidoz N, Kirova YM.

Cancer Radiother. 2014 Jan;18(1):15-22. doi: 10.1016/j.canrad.2013.07.149. Epub 2013 Dec 6. French.

PMID:
24316350
19.

Helical tomotherapy for inoperable breast cancer: a new promising tool.

Chira C, Kirova YM, Liem X, Campana F, Peurien D, Amessis M, Fournier-Bidoz N, Pierga JY, Dendale R, Bey P, Fourquet A.

Biomed Res Int. 2013;2013:264306. doi: 10.1155/2013/264306. Epub 2013 Sep 2.

20.

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy.

Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, Bossi A, Le Prisé E, Guerif S, Simon JM, Dubray B, Zhu J, Lagrange JL, Pommier P, Gnep K, Acosta O, De Crevoisier R.

World J Urol. 2014 Jun;32(3):743-51. doi: 10.1007/s00345-013-1146-8. Epub 2013 Aug 29.

21.

Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors.

Chira C, Taussky D, Gruszczynski N, Meissner A, Larrivée S, Carrier JF, Donath D, Delouya G.

Brachytherapy. 2013 Nov-Dec;12(6):603-7. doi: 10.1016/j.brachy.2013.05.005. Epub 2013 Jul 24.

PMID:
23891340
22.

Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication.

Chira C, Delouya G, Larrivée S, Carrier JF, Taussky D.

Radiat Oncol. 2013 Jul 9;8:177. doi: 10.1186/1748-717X-8-177.

23.

Hill-Climbing search and diversification within an evolutionary approach to protein structure prediction.

Chira C, Horvath D, Dumitrescu D.

BioData Min. 2011 Jul 30;4:23. doi: 10.1186/1756-0381-4-23.

24.

Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy.

Chira C, Jacob J, Derhem N, Bollet MA, Campana F, Marchand V, Pierga JY, Fourquet A, Kirova YM.

J Neurooncol. 2011 Nov;105(2):401-8. doi: 10.1007/s11060-011-0607-4. Epub 2011 Jun 5.

PMID:
21643988
25.

[High dose for prostate irradiation with image guided radiotherapy: contribution of intensity modulation arctherapy].

Jouyaux F, De Crevoisier R, Manens JP, Bellec J, Cazoulat G, Haigron P, Chira C, Le Prisé E, Lafond C.

Cancer Radiother. 2010 Dec;14(8):679-89. doi: 10.1016/j.canrad.2010.03.003. Epub 2010 May 31. French.

26.

[Image-guided radiotherapy: rational, modalities and results].

de Crevoisier R, Louvel G, Cazoulat G, Leseur J, Lafond C, Lahbabi K, Chira C, Lagrange JL.

Bull Cancer. 2009 Jan;96(1):123-32. doi: 10.1684/bdc.2009.0801. French.

28.

[Prinzmetal angina as an accompanying symptom in contrast medium injection].

Oprian O, Chira C, Pieptea R.

Dtsch Med Wochenschr. 1977 Mar 11;102(10):371-3. German. No abstract available.

PMID:
837837

Supplemental Content

Support Center